Aparna Sahoo, MD
Dr. Sahoo is a board-certified internist and nephrologist joining ProKidney in 2023 as Vice President, Head of Clinical Development. Aparna brings extensive experience in global clinical development in Nephrology and Immunology from prior leadership roles at Johnson & Johnson, AstraZeneca, Allergan, and Parexel.
Most recently, Aparna led a large Phase 3 global clinical development program for Tremfya®, including combination biologic and device development, in inflammatory bowel disease as a Senior Director within the Immunology division of Janssen/Johnson & Johnson Innovative Medicine. Prior to her career in clinical research, Aparna spent 12 years in clinical practice as a nephrologist and internist primarily in central New Jersey in academia and private practice. She completed her medical residency in internal medicine at Rutgers-Robert Wood Johnson Medical School in New Brunswick, NJ and nephrology fellowship at New York Medical College in Valhalla, NY.